These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1963497)

  • 21. Neurotransmitters, anxiety and benzodiazepines: a behavioral review.
    Shephard RA
    Neurosci Biobehav Rev; 1986; 10(4):449-61. PubMed ID: 2880326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.
    Morilak DA; Frazer A
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):193-218. PubMed ID: 15003145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety.
    Roy-Byrne PP
    J Clin Psychiatry; 2005; 66 Suppl 2():14-20. PubMed ID: 15762815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disinhibition of the rat prelimbic cortex promotes serotonergic activation of the dorsal raphe nucleus and panicolytic-like behavioral effects.
    Yamashita PS; Spiacci A; Hassel JE; Lowry CA; Zangrossi H
    J Psychopharmacol; 2017 Jun; 31(6):704-714. PubMed ID: 28071216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin agents in anxiety.
    Taylor DP
    Ann N Y Acad Sci; 1990; 600():545-56; discussion 556-7. PubMed ID: 2252334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias.
    Sullivan GM; Coplan JD; Kent JM; Gorman JM
    Biol Psychiatry; 1999 Nov; 46(9):1205-18. PubMed ID: 10560026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin related functions in panic-anxiety: a critical overview.
    Coplan JD; Gorman JM; Klein DF
    Neuropsychopharmacology; 1992 May; 6(3):189-200. PubMed ID: 1534662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New molecular targets for antianxiety interventions.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent.
    Pisu C; Pira L; Pani L
    Behav Pharmacol; 2010 Oct; 21(7):649-53. PubMed ID: 20802307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies.
    Kalk NJ; Nutt DJ; Lingford-Hughes AR
    J Psychopharmacol; 2011 Jan; 25(1):3-16. PubMed ID: 20530586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin: a common neurobiologic substrate in anxiety and depression.
    Eison MS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin receptors in depression and anxiety: Insights from animal studies.
    Żmudzka E; Sałaciak K; Sapa J; Pytka K
    Life Sci; 2018 Oct; 210():106-124. PubMed ID: 30144453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiety and the benzodiazepine receptor.
    Norman TR; Burrows GD
    Prog Brain Res; 1986; 65():73-90. PubMed ID: 3024225
    [No Abstract]   [Full Text] [Related]  

  • 37. [Panic attacks and anxiety depression. Clinical, biological and therapeutic update].
    Martinot JL; Raffaitin F; Olié JP
    Encephale; 1986; 12(6):321-6. PubMed ID: 3816679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors.
    Bali A; Jaggi AS
    Pharmacol Res; 2013 Oct; 76():49-57. PubMed ID: 23892268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.